Incremental clinical and economic burden of suspected respiratory infections due to multi-drug-resistant Pseudomonas aeruginosa in the United States

Background Multi-drug resistant (MDR) Pseudomonas aeruginosa can negatively affect patients and hospitals. Aim To evaluate excess mortality and cost burden among patients hospitalized with suspected respiratory infections due to MDR P. aeruginosa vs patients with non-MDR P. aeruginosa in 78 United States (US) hospitals. Methods This study analyzed electronically captured microbiological and outcomes data of patients hospitalized with...